Douglas Lane & Associates LLC Increases Position in Intuitive Surgical, Inc. $ISRG

Douglas Lane & Associates LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 112.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,898 shares of the medical equipment provider's stock after purchasing an additional 54,499 shares during the period. Douglas Lane & Associates LLC's holdings in Intuitive Surgical were worth $41,842,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. State Street Corp boosted its stake in shares of Intuitive Surgical by 1.0% during the 4th quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider's stock worth $8,892,753,000 after buying an additional 162,264 shares during the last quarter. Invesco Ltd. increased its position in shares of Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider's stock valued at $2,338,350,000 after acquiring an additional 611,268 shares during the last quarter. Bank of America Corp DE raised its holdings in Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock worth $1,667,388,000 after acquiring an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Intuitive Surgical during the second quarter valued at approximately $1,335,753,000. Finally, Amundi boosted its position in Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $9.42 during mid-day trading on Friday, hitting $424.83. 691,103 shares of the company's stock traded hands, compared to its average volume of 2,414,546. The firm has a 50 day simple moving average of $384.95 and a two-hundred day simple moving average of $411.17. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock has a market cap of $150.08 billion, a price-to-earnings ratio of 48.71, a P/E/G ratio of 3.13 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company's quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.81 earnings per share. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst upgrades support the stock: Barclays initiated coverage at Overweight and was also reported to have upgraded ISRG to “strong buy,” citing the company’s high-quality business and durable position in medical devices. Barclays bullish initiation
• Positive Sentiment: Piper Sandler issued a Buy rating, adding to the constructive analyst sentiment surrounding Intuitive Surgical. Piper Sandler Buy rating
• Positive Sentiment: The da Vinci SP single-port platform is gaining momentum: Rising procedures, utilization and system placements, along with broader indications and international adoption, could create another sizable growth franchise for ISRG. Single-port platform growth
• Positive Sentiment: Recent optimism also reflects expectations for continued year-over-year revenue and earnings growth. Intuitive Surgical’s latest reported quarter showed revenue growth of 18.4% and earnings that exceeded analyst estimates, reinforcing its fundamental momentum.
• Neutral Sentiment: Wall Street’s bullish consensus comes with a caveat: Average brokerage recommendations suggest buying ISRG, but such ratings can be overly optimistic because they are produced by sell-side analysts. Wall Street analyst consensus
• Neutral Sentiment: Premarket trading indicated little movement, suggesting investors may be waiting for additional information from the upcoming earnings release before making larger moves.
• Negative Sentiment: Competition and valuation remain risks. Commentary highlighted growing rivalry, particularly from Johnson & Johnson, while ISRG’s premium valuation could limit upside if growth or procedure volumes disappoint. Jim Cramer questioned the company’s competitive outlook for these reasons. Competition concerns

Insiders Place Their Bets

In other Intuitive Surgical news, Director Gary Guthart sold 10,000 shares of the stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the transaction, the director directly owned 1,245,679 shares of the company's stock, valued at $498,271,600. This represents a 0.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 77 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president owned 881 shares of the company's stock, valued at $330,877.17. This trade represents a 8.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock worth $4,891,989 in the last 90 days. Corporate insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Citigroup lowered their price target on Intuitive Surgical from $590.00 to $500.00 and set a "buy" rating on the stock in a research report on Friday, July 17th. TD Cowen cut shares of Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Tuesday, July 28th. Evercore set a $430.00 target price on shares of Intuitive Surgical in a report on Monday, July 6th. Oppenheimer upgraded shares of Intuitive Surgical from a "market perform" rating to an "outperform" rating and set a $500.00 price target for the company in a research note on Wednesday, August 12th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Intuitive Surgical in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $502.53.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company's products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.